References
- Chen W, Lynd LD, FitzGerald JM, et al. Canadian Respiratory Research Network. Excess medical costs in patients with asthma and the role of comorbidity. Eur Respir J. 2016;48(6):1584–1592. doi:10.1183/13993003.01141-201627824603
- Cortaredona S, Ventelou B. The extra cost of comorbidity: multiple illnesses and the economic burden of non-communicable diseases. BMC Med. 2017;15(1):216. doi:10.1186/s12916-017-0978-229221453
- Cadarette SM, Wong L. An introduction to health care administrative data. Can J Hosp Pharm. 2015;68(3):232–237. doi:10.4212/cjhp.v68i3.145726157185
- Riley GF. Administrative and claims records as sources of health care cost data. Med Care. 2009;47(7 Suppl 1):S51–S55. doi:10.1097/MLR.0b013e31819c95aa19536019
- Preussler JM, Mau LW, Majhail NS, et al. Administrative claims data for economic analyses in hematopoietic cell transplantation: challenges and opportunities. Biol Blood Marrow Transplant. 2016;22(10):1738–1746. doi:10.1016/j.bbmt.2016.05.00527184624
- Cho JH, Feldman M. Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies. Nat Med. 2015;21(7):730–738. doi:10.1038/nm.389726121193
- Ford JH, Schroeder K, Nyhuis AW, Foster SA, Aurora SK. Cycling through migraine preventive treatments: implications for all-cause total direct costs and disease-specific costs. J Manag Care Spec Pharm. 2019;25(1):46–59. doi:10.18553/jmcp.2018.1805830044691
- Voss EA, Ma Q, Ryan PB. The impact of standardizing the definition of visits on the consistency of multi-database observational health research. BMC Med Res Methodol. 2015;15:13. doi:10.1186/s12874-015-0001-625887092
- Birnbaum HG, Kessler RC, Lowe SW, et al. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons and their family members in 2000. Curr Med Res Opin. 2005;21(2):195–206. doi:10.1185/030079904X2030315801990
- Kappelman MD, Rifas-Shiman SL, Porter CQ, et al. Direct health care costs of Crohn’s disease and ulcerative colitis in US children and adults. Gastroenterology. 2008;135(6):1907–1913. doi:10.1053/j.gastro.2008.09.01218854185
- Kowal SL, Dall T, Chakrabarti R, Storm MV, Jain A. The current and projected economic burden of Parkinson’s disease in the United States. Mov Disord. 2013;28(3):311–318. doi:10.1002/mds.2529223436720
- Kan HJ, Song X, Johnson BH, Bechtel B, O’Sullivan D, Molta CT. Healthcare utilization and costs of systemic lupus erythematosus in Medicaid. Biomed Res Int. 2013;2013:808391. doi:10.1155/2013/80839123484162
- Wimo A, Reed CC, Dodel R, et al. The GERAS study: a prospective observational study of costs and resource use in community dwellers with Alzheimer’s disease in three European countries – study design and baseline findings. J Alzheimers Dis. 2013;36(2):385–399. doi:10.3233/JAD-12239223629588